Log in to your Inderes Free account to see all free content on this page.
Nykode Therapeutics
Less than 1K followers
NYKD
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Nykode Therapeutics is a biotechnology company. The company specializes in the research and development of immunological therapies and vaccines. The solutions are mainly used for the treatment of patients with cancer and other serious health conditions that require long-term treatment. The largest operations are in the European market.
Read moreMarket cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
25.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
Nykode Therapeutics - Quarterly Report Q3 2025
Nykode Therapeutics - Invitation to Q3 2025 Financial Results Presentation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio